|
静脉普罗帕酮和毛花甙C转复阵发性非瓣膜病心房颤动 |
| |
程康安 徐成斌 黄捷英 刘秋杰 焦镇
李莉 丁秀兰 杨芳 沈潞华 吴宁
【摘要】 目的 对比普罗帕酮和毛花甙C在转复阵发性非瓣膜病心房颤动（房颤）的作用。方法 房颤发作在0.5～72小时的患者，随机分入普罗帕酮组和毛花甙C组。静脉推注毛花甙C0.4～0.6mg或普罗帕酮70～210mg，观察房颤转复情况及心室率的变化。结果 共70例患者，阵发性房颤病程（28.2±42.0）个月。毛花甙C组34例，转复成功15例（44.1％）；普罗帕酮组36例，转复成功28例（77.8％）；P＜0.01。转复成功时间：毛花甙C组（86.1±53.5）分钟，普罗帕酮组（47.6±37.7）分钟，P＝0.05；未转复成功者的心室率下降情况：毛花甙C组由（124.6±20.3）次／min降至（93.1±19.2）次／min,普罗帕酮组由（124.0±32.1）次／min降至（118.6±21.0）次／min，P＞0.1。结论 在阵发性房颤的转复中静脉普罗帕酮的成功率高于毛花甙C，普罗帕酮转复时间较毛花甙C短，而毛花甙C在减慢心室率方面优于普罗帕酮。
【关键词】 心房颤动 普罗帕酮 毛花甙C
Comparison of propafenone and cedilanid in
reverting paroxysmal atrial fibrillation in non-rheumatic patients
CHENG Kangan XU Chengbin HUANG Jieying et al
Department of Cardiology, Peking Union Medical College Hospital, Beijing 100730
【Abstract】 Objective To compare efficacies of propafenone and cedilanid in reverting paroxysmal atrial fibrillation in non-rheumatic patients. Methods The duration of atrial fibrillation before enrollment was between 0.5 and 72 hours. Patients were randomly divided into propafenone group and cedilanid group. Both propafenone 70-210 mg and cedilanid 0.4-0.6 mg were given intravenously. The patients were monitored for rhythms, heart rate, BP and side effects during study. Results Seventy patients were enrolled in the study. The history of paroxysmal atrial fibrillation was 28.0±42.0 months. The success rate of cardioversion for atrial fibrillation was significantly higher in propafenone group (28/36, 77.8%) than in cedilanid group (15/34,44.1%) (P<0.001). The times to reversion for propafenone and cedilanid were 47.6±37.7 and 86.1±53.5 minutes (P=0.05) respectively. In patients whose cardioversion failed the ventricular response tended to decrease more in cedilanid group (124.6±20.3/min to 93.1±19.2/min) than in propafenone group (124.0±32.1/min to 118.6±21.0/m[1] [2] 下一页
上一个医学论文： 普伐他汀对血小板聚集 血小板表面 颗粒膜蛋白140及血栓烷素B2的抑制作用
下一个医学论文： 伴发干燥综合征的原发性胆汁性肝硬化肝功能衰竭的肝移植治疗一例
|
|
|
|
|
|
|
您现在的位置： 绿色健康网 >> 医学论文 >> 内科论文 >> 正文